Shangwen Jing
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shangwen Jing has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Qi Wang
Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China; Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China
2 shared publications - Ailin Zhong
Office of International Exchange and Cooperation, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People’s Republic of China
1 shared publication Ailing Liu
School of Public Health and Management, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People’s Republic of China
1 shared publication- Dandan Cao
Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangdong, Guangzhou, China; Medical College of Acupuncture-Moxibustion and Rehabilitation, Guangzhou University of Chinese Medicine, Guangdong, Guangzhou, China
1 shared publication - David Bishai
School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China
1 shared publication - Dishu Zhou
Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 1 July 2025
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 18, 3827-3841
Uncovering Diagnostic Correlations Between Traditional Chinese and Western Medicine Using Instrumental Variable Models in Cardiometabolic Patients: Evidence from 1.2 Million Records
Background: Little is known about the relationship between syndromes in Traditional Chinese Medicine (TCM) and chronic diseases coded by Western Medicine (WM). TCM hospitals where both WM and TCM are practiced offer an opportunity to assess this relationship. TCM, based on syndrome differentiation and treatment, may aid in guiding treatment and predicting length of stay and healthcare costs. However, inconsistent coding of TCM syndromes arises due to variations in diagnostic interpretation, subjective assessment, and lack of standardized coding practices. The objective was to assess the correlation between WM diagnoses and TCM syndromes, accounting for diagnostic miscoding in the data. Methods: We examined discharge data from 1,218,224 records for patients aged 45 and above, diagnosed with cardiometabolic diseases and admitted to TCM hospitals between 2017 and 2022, stays ranging from 24-hours to 90 days. Latent class analysis (LCA) was used to measure the correlation between TCM syndromes and WM. To address potential diagnostic errors, we applied bivariate probit models with instrumental variable (IV). Results: There were 580,698 (47.67%) records for males, while 989,702 (81.24%) records from Tertiary-A hospitals. The LCA and probit models revealed that TCM syndrome diagnoses had a high ratio of noise to signal. After correcting for diagnostic errors, significant associations were found between WM diagnoses and TCM syndromes. Notably, diabetes mellitus was strongly associated with syndrome/pattern of qi and yin deficiency (coefficient = 2.711); cerebrovascular diseases showed strong associations with syndrome/pattern of qi deficiency with blood stasis (coefficient = 2.433) and syndrome/pattern of wind and phlegm blocking collaterals (coefficient = 3.176). All patterns had strong marginal effects (P < 0.001). Conclusion: This large-scale study quantitatively maps the relationship between TCM and WM diagnoses. It introduces a new statistical approach to understanding the correlation between these two diagnostic systems, offering insights into integrated medicine for secondary prevention.
- 1 July 2025
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 18, 3827-3841
Open AccessUncovering Diagnostic Correlations Between Traditional Chinese and Western Medicine Using Instrumental Variable Models in Cardiometabolic Patients: Evidence from 1.2 Million Records
Background: Little is known about the relationship between syndromes in Traditional Chinese Medicine (TCM) and chronic diseases coded by Western Medicine (WM). TCM hospitals where both WM and TCM are practiced offer an opportunity to assess this relationship. TCM, based on syndrome differentiation and treatment, may aid in guiding treatment and predicting length of stay and healthcare costs. However, inconsistent coding of TCM syndromes arises due to variations in diagnostic interpretation, subjective assessment, and lack of standardized coding practices. The objective was to assess the correlation between WM diagnoses and TCM syndromes, accounting for diagnostic miscoding in the data. Methods: We examined discharge data from 1,218,224 records for patients aged 45 and above, diagnosed with cardiometabolic diseases and admitted to TCM hospitals between 2017 and 2022, stays ranging from 24-hours to 90 days. Latent class analysis (LCA) was used to measure the correlation between TCM syndromes and WM. To address potential diagnostic errors, we applied bivariate probit models with instrumental variable (IV). Results: There were 580,698 (47.67%) records for males, while 989,702 (81.24%) records from Tertiary-A hospitals. The LCA and probit models revealed that TCM syndrome diagnoses had a high ratio of noise to signal. After correcting for diagnostic errors, significant associations were found between WM diagnoses and TCM syndromes. Notably, diabetes mellitus was strongly associated with syndrome/pattern of qi and yin deficiency (coefficient = 2.711); cerebrovascular diseases showed strong associations with syndrome/pattern of qi deficiency with blood stasis (coefficient = 2.433) and syndrome/pattern of wind and phlegm blocking collaterals (coefficient = 3.176). All patterns had strong marginal effects (P < 0.001). Conclusion: This large-scale study quantitatively maps the relationship between TCM and WM diagnoses. It introduces a new statistical approach to understanding the correlation between these two diagnostic systems, offering insights into integrated medicine for secondary prevention.
- 14 February 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 61 (9) , 6864-6892
Exosomes: A Cellular Communication Medium That Has Multiple Effects On Brain Diseases
Exosomes, as membranous vesicles generated by multiple cell types and secreted to extracellular space, play a crucial role in a range of brain injury–related brain disorders by transporting diverse proteins, RNA, DNA fragments, and other functional substances. The nervous system’s pathogenic mechanisms are complicated, involving pathological processes like as inflammation, apoptosis, oxidative stress, and autophagy, all of which result in blood-brain barrier damage, cognitive impairment, and even loss of normal motor function. Exosomes have been linked to the incidence and progression of brain disorders in recent research. As a result, a thorough knowledge of the interaction between exosomes and brain diseases may lead to the development of more effective therapeutic techniques that may be implemented in the clinic. The potential role of exosomes in brain diseases and the crosstalk between exosomes and other pathogenic processes were discussed in this paper. Simultaneously, we noted the delicate events in which exosomes as a media allow the brain to communicate with other tissues and organs in physiology and disease, and compiled a list of natural compounds that modulate exosomes, in order to further improve our understanding of exosomes and propose new ideas for treating brain disorders.
- 14 February 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 61 (9) , 6864-6892
Exosomes: A Cellular Communication Medium That Has Multiple Effects On Brain Diseases
Exosomes, as membranous vesicles generated by multiple cell types and secreted to extracellular space, play a crucial role in a range of brain injury–related brain disorders by transporting diverse proteins, RNA, DNA fragments, and other functional substances. The nervous system’s pathogenic mechanisms are complicated, involving pathological processes like as inflammation, apoptosis, oxidative stress, and autophagy, all of which result in blood-brain barrier damage, cognitive impairment, and even loss of normal motor function. Exosomes have been linked to the incidence and progression of brain disorders in recent research. As a result, a thorough knowledge of the interaction between exosomes and brain diseases may lead to the development of more effective therapeutic techniques that may be implemented in the clinic. The potential role of exosomes in brain diseases and the crosstalk between exosomes and other pathogenic processes were discussed in this paper. Simultaneously, we noted the delicate events in which exosomes as a media allow the brain to communicate with other tissues and organs in physiology and disease, and compiled a list of natural compounds that modulate exosomes, in order to further improve our understanding of exosomes and propose new ideas for treating brain disorders.
- 29 June 2023
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 38 (7) , 2443-2456
Hesperetin attenuates cognitive dysfunction via SIRT6/NLRP3 pathway in scopolamine-induced mice
Neuroinflammation is a critical feature in the pathogenesis of neurodegenerative disorders such as Alzheimer’s disease (AD). Hesperetin can exert anti-inflammatory, antioxidant and other neuroprotective effects. In this study, the scopolamine (SCOP)-induced cognitive dysfunction in mice model was used to evaluate the neuroprotective effects of hesperetin. Behavioral tests (Morris water maze, open field, and novel object recognition tests) were conducted to evaluate the effect of hesperetin on cognitive dysfunction behaviors. Nissl staining and Immunofluorescence were used to evaluate hippocampal neuronal damage and microglial activation in mice. The levels of proinflammatory factors, oxidant stress, and the cholinergic neurotransmitter were detected by real-time quantitative fluorescence PCR (RT-qPCR) or biochemical reagent kits. Western blotting was used to detect the relative protein expression of the sirtuin 6 (SIRT6) / NOD-like receptor thermal protein domain associated protein 3 (NLRP3) pathway. Results showed that hesperetin could ameliorate SCOP-induced cognitive impairment and neuronal damage, and regulate the levels of cholinergic neurotransmitters in the hippocampal of AD mice. Hesperetin could also enhance antioxidant defense by regulating the levels of reactive oxygen species (ROS), malondialdehyde (MDA), superoxide dismutase (SOD), and catalase (CAT). Hesperetin exerted anti-neuroinflammation effects through inhibiting of microglia activation and down-regulating the mRNA transcript levels of inflammatory cytokines, such as tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), interleukin-1β (IL-1β), cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS). Meanwhile, hesperetin could attenuate the expression of NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC), thioredoxin-interacting protein (TXNIP), and caspase-1 p20 and upregulate the expression of SIRT6 in SCOP-induced mice. Overall, our study suggested that hesperetin might ameliorate SCOP-induced cognitive dysfunction by improving cholinergic system dysfunction and suppressing oxidative stress and attenuating neuroinflammation via SIRT6/NLRP3 pathway in mice.
- 29 June 2023
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 38 (7) , 2443-2456
Hesperetin attenuates cognitive dysfunction via SIRT6/NLRP3 pathway in scopolamine-induced mice
Neuroinflammation is a critical feature in the pathogenesis of neurodegenerative disorders such as Alzheimer’s disease (AD). Hesperetin can exert anti-inflammatory, antioxidant and other neuroprotective effects. In this study, the scopolamine (SCOP)-induced cognitive dysfunction in mice model was used to evaluate the neuroprotective effects of hesperetin. Behavioral tests (Morris water maze, open field, and novel object recognition tests) were conducted to evaluate the effect of hesperetin on cognitive dysfunction behaviors. Nissl staining and Immunofluorescence were used to evaluate hippocampal neuronal damage and microglial activation in mice. The levels of proinflammatory factors, oxidant stress, and the cholinergic neurotransmitter were detected by real-time quantitative fluorescence PCR (RT-qPCR) or biochemical reagent kits. Western blotting was used to detect the relative protein expression of the sirtuin 6 (SIRT6) / NOD-like receptor thermal protein domain associated protein 3 (NLRP3) pathway. Results showed that hesperetin could ameliorate SCOP-induced cognitive impairment and neuronal damage, and regulate the levels of cholinergic neurotransmitters in the hippocampal of AD mice. Hesperetin could also enhance antioxidant defense by regulating the levels of reactive oxygen species (ROS), malondialdehyde (MDA), superoxide dismutase (SOD), and catalase (CAT). Hesperetin exerted anti-neuroinflammation effects through inhibiting of microglia activation and down-regulating the mRNA transcript levels of inflammatory cytokines, such as tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), interleukin-1β (IL-1β), cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS). Meanwhile, hesperetin could attenuate the expression of NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC), thioredoxin-interacting protein (TXNIP), and caspase-1 p20 and upregulate the expression of SIRT6 in SCOP-induced mice. Overall, our study suggested that hesperetin might ameliorate SCOP-induced cognitive dysfunction by improving cholinergic system dysfunction and suppressing oxidative stress and attenuating neuroinflammation via SIRT6/NLRP3 pathway in mice.